150 related articles for article (PubMed ID: 29417642)
21. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
22. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells.
Xu Y; Yu H; Qin H; Kang J; Yu C; Zhong J; Su J; Li H; Sun L
Cancer Lett; 2012 Jan; 314(2):232-43. PubMed ID: 22019047
[TBL] [Abstract][Full Text] [Related]
24. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
25. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines.
Woessmann W; Chen X; Borkhardt A
Cancer Chemother Pharmacol; 2002 Nov; 50(5):397-404. PubMed ID: 12439598
[TBL] [Abstract][Full Text] [Related]
26. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
27. Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells.
Hu G; Zhang J; Xu F; Deng H; Zhang W; Kang S; Liang W
Cancer Sci; 2018 May; 109(5):1357-1368. PubMed ID: 29516570
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
29. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer.
Leisching GR; Loos B; Botha MH; Engelbrecht AM
Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060
[TBL] [Abstract][Full Text] [Related]
30. Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity.
Piaggi S; Raggi C; Corti A; Pitzalis E; Mascherpa MC; Saviozzi M; Pompella A; Casini AF
Carcinogenesis; 2010 May; 31(5):804-11. PubMed ID: 20106899
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation.
Schweyer S; Soruri A; Meschter O; Heintze A; Zschunke F; Miosge N; Thelen P; Schlott T; Radzun HJ; Fayyazi A
Br J Cancer; 2004 Aug; 91(3):589-98. PubMed ID: 15266324
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.
Cui W; Yazlovitskaya EM; Mayo MS; Pelling JC; Persons DL
Mol Carcinog; 2000 Dec; 29(4):219-28. PubMed ID: 11170260
[TBL] [Abstract][Full Text] [Related]
33. Carvacrol inhibits proliferation and induces apoptosis in human colon cancer cells.
Fan K; Li X; Cao Y; Qi H; Li L; Zhang Q; Sun H
Anticancer Drugs; 2015 Sep; 26(8):813-23. PubMed ID: 26214321
[TBL] [Abstract][Full Text] [Related]
34. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.
Tsai TT; Guttapalli A; Agrawal A; Albert TJ; Shapiro IM; Risbud MV
J Bone Miner Res; 2007 Jul; 22(7):965-74. PubMed ID: 17371162
[TBL] [Abstract][Full Text] [Related]
35. MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.
Chen CH; Hsia TC; Yeh MH; Chen TW; Chen YJ; Chen JT; Wei YL; Tu CY; Huang WC
Mol Oncol; 2017 Sep; 11(9):1273-1287. PubMed ID: 28632938
[TBL] [Abstract][Full Text] [Related]
36. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
37. Resistance to MEK inhibitors: should we co-target upstream?
Poulikakos PI; Solit DB
Sci Signal; 2011 Mar; 4(166):pe16. PubMed ID: 21447797
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
39. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells.
Motomura W; Tanno S; Takahashi N; Nagamine M; Fukuda M; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2005 Jun; 332(1):89-94. PubMed ID: 15896303
[TBL] [Abstract][Full Text] [Related]
40. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
